These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2849851)

  • 1. Erythrocyte sodium transport in Bartter's syndrome.
    Uchiyama M; Shah V; Daman Willems C; Dillon MJ
    Acta Paediatr Scand; 1988 Nov; 77(6):873-8. PubMed ID: 2849851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of hypokalemia corrects the abnormalities in erythrocyte sodium transport in Bartter's syndrome.
    Korff JM; Siebens AW; Gill JR
    J Clin Invest; 1984 Nov; 74(5):1724-9. PubMed ID: 6501567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytic sodium and potassium pump function in Bartter's syndrome.
    Jest P; Pedersen KE; Klitgaard NA; Thomsen N; Kjaer E; Simonsen E; Jacobsen JG
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):61-6. PubMed ID: 2741641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of erythrocyte sodium transport systems in Bartter's syndrome.
    Sechi LA; Melis A; Bartoli E
    Am J Nephrol; 1992; 12(3):137-43. PubMed ID: 1329511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment with prostaglandin synthetase inhibitors on the erythrocyte sodium transport abnormality of Bartter's syndrome.
    Cole CH; O'Regan S
    Pediatr Res; 1981 Jun; 15(6):926-9. PubMed ID: 6787547
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K; Schreiber V; Dvoráková J
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man.
    Gordon RD; Tunny TJ; Klemm SA; Hamlet SM
    J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane ion transport in Bartter's syndrome: evidence for a new syndrome subtype.
    Koren W; Peleg E; Rosenthal T; Postnov YV
    Hypertension; 1997 Dec; 30(6):1338-41. PubMed ID: 9403550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous derangement of cellular sodium metabolism in Bartter's syndrome. Description of two cases and review of the literature.
    Sechi LA; Melis A; Faedda R; Tedde R; Bartoli E
    Panminerva Med; 1992; 34(2):85-92. PubMed ID: 1408334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sodium-lithium countertransport in red cells of patients with Bartter's syndrome.
    Mattioli M; Delva P; Lechi C; Minuz P; Lechi A; Scuro LA
    J Endocrinol Invest; 1984 Feb; 7(1):61-3. PubMed ID: 6715799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bartter's syndrome--observations on the pathophysiology.
    Solomon LR; Bobinski H; Astley P; Goldby FS; Mallick NP
    Q J Med; 1982; 51(203):251-70. PubMed ID: 7146310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin and atrial natriuretic peptide in Bartter's syndrome.
    Gordon RD; Tunny TJ; Klemm SA
    N Engl J Med; 1986 Aug; 315(7):459. PubMed ID: 2942775
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH; Hewitt GJ; Mitchell MD
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A defect in platelet aggregation in Bartter's syndrome.
    Stoff JS; Stemerman M; Steer M; Salzman E; Brown RS
    Am J Med; 1980 Feb; 68(2):171-80. PubMed ID: 6243857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP; Telfer N; Zia P; Speckart P; Golub M; Rude R
    Am J Med; 1976 May; 60(6):785-97. PubMed ID: 798488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Bartter's syndrome with indomethacin.
    Garin EH; Fennell RS; Iravani A; Richard GA
    Am J Dis Child; 1980 Mar; 134(3):258-61. PubMed ID: 6767392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the pathogenesis of Bartter's syndrome.
    Baehler RW; Work J; Kotchen TA; McMorrow G; Guthrie G
    Am J Med; 1980 Dec; 69(6):933-8. PubMed ID: 7446558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte Na+ and K+ transport systems in children with Bartter syndrome: increase in passive sodium permeability.
    Mongeau JG; Garay R; de Mendonca M; Broyer M; Meyer P
    Kidney Int; 1983 Mar; 23(3):530-5. PubMed ID: 6302364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A
    Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A variant of Bartter's syndrome. Bartter's syndrome associated with hydramnios, prematurity, hypercalciuria and nephrocalcinosis.
    Ohlsson A; Sieck U; Cumming W; Akhtar M; Serenius F
    Acta Paediatr Scand; 1984 Nov; 73(6):868-74. PubMed ID: 6395627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.